Search

everythinglearnresearchcommunity

for

Search:↓

Four genetic risk areas related to male-pattern baldness were identified, with WNT signaling playing a role in its development.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

Laser therapy and hair growth factors significantly improve hair density in male baldness.

A new method accurately measures nine specific hormones in human blood.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Stem cell treatments can potentially treat baldness, with one trial showing hair growth after injecting a hair-stimulating complex, and no safety issues were reported.

Prepubertal girls with hypertrichosis have more sensitive androgen receptors, leading to increased body hair growth.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Dexamethasone increases the activity of androgen receptors in human skin cells, which may link it to certain types of hair loss.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

Targeting specific genes in certain pathways may help treat male pattern baldness.

Limosilactobacillus reuteri from honeybees may promote hair growth by activating a specific cell pathway.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Ishophloroglucin A from Ishige okamurae may be a natural alternative for treating hair loss by inhibiting 5α-reductase and promoting hair growth.

24-Hydroxycholesterol reduces DHT formation in brain cancer cells, linking cholesterol and hormone metabolism.

Plant-derived nanoparticles from Polygoni Multiflori Radix promote hair growth better than Minoxidil by affecting androgen pathways.

Targeting CXCL12 may help treat hair loss caused by androgens.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Finasteride helps reduce heart issues and improves heart function.